KMC
CLPT icon

Kirr Marbach & Co’s ClearPoint Neuro CLPT Stock Holding History

Kirr Marbach & Co’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-44,200
Closed -$496K – 54
2021
Q4 		$496K Sell
44,200
-5,000
-10% -$74.9K 0.13% 46
2021
Q3 		$873K Buy
49,200
+4,000
+9% +$75K 0.26% 41
2021
Q2 		$863K Buy
45,200
+5,200
+13% +$100K 0.25% 37
2021
Q1 		$846K Sell
40,000
-2,200
-5% -$47.1K 0.24% 40
2020
Q4 		$671K Hold
42,200
– – 0.21% 41
2020
Q3 		$230K Hold
42,200
– – 0.09% 48
2020
Q2 		$150K Hold
42,200
– – 0.05% 51
2020
Q1 		$218K Sell
42,200
-2,000
-5% -$9.82K 0.09% 48
2019
Q4 		$212K Buy
44,200
+1,000
+2% +$4.14K 0.05% 52
2019
Q3 		$219K Buy
+43,200
New +$177K 0.05% 51

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Kirr Marbach & Co's CLPT Position: Q1 2022 in Review

Kirr Marbach & Co sold out of ClearPoint Neuro (CLPT) in Q1 2022, closing a stake of 44,200 shares — an estimated $496K sold.

Kirr Marbach & Co first reported a position in CLPT in Q3 2019 and held it in 10 quarters. The position peaked at $873K in Q3 2021. 64 funds tracked by Wall St. Rank hold CLPT as of Q1 2022.

  • Kirr Marbach & Co reported no remaining ClearPoint Neuro position as of Q1 2022 after selling out during the quarter.
  • Kirr Marbach & Co sold 44,200 ClearPoint Neuro shares in Q1 2022, an estimated $496K.
  • Kirr Marbach & Co first reported a position in ClearPoint Neuro in Q3 2019 and held it in 10 quarters.
  • Kirr Marbach & Co's ClearPoint Neuro position peaked at $873K in Q3 2021.
  • 64 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2022.

Based on Kirr Marbach & Co's 13F filing for Q1 2022, filed 3 May 2022.